Open Access Opinion Article ID: ASB-5-118

    The potential use of O6-Benzylguanine, and O6-Methylguanine for the treatment of Alzheimer’s Disease, and T. brucei group trypanosomes infections

    Philip G Penketh*, Raymond P Baumann and Krishnamurthy Shyam

    Very recently we had published a paper entitled ‘The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer’s Disease’ [1]. Our paper was a development from an observation by others from 1997, where a remarkable remission in Dementia was observed in cancer patients following treatment with the chemotherapeutic agent BCNU (Carmustine, 1,3-Bis(2-chloroethyl)-1-nitrosourea) [2]. 


    Published on: Aug 13, 2022 Pages: 10-11

    Full Text PDF Full Text HTML DOI: 10.17352/asb.000018
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on ASB

    Help ? Google Reviews 11